Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill Patients
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Doripenem (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Septic shock
- Focus Pharmacokinetics
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Feb 2012 New trial record